Subchapter C - SUPPLEMENTAL REBATES OR PROGRAM BENEFITS FOR PRESCRIPTION DRUGS
- Section 549.0101 - [Effective 4/1/2025] Definitions
- Section 549.0102 - [Effective 4/1/2025] Requirement To Negotiate For Supplemental Rebates For Certain Programs
- Section 549.0103 - [Effective 4/1/2025] Voluntary Negotiation For Manufacturer And Labeler Supplemental Rebates
- Section 549.0104 - [Effective 4/1/2025] Considerations In Supplemental Rebate Negotiations
- Section 549.0105 - [Effective 4/1/2025] Required Disclosures In Negotiations For Supplemental Rebates
- Section 549.0106 - [Effective 4/1/2025] Program Benefits Instead Of Supplemental Rebates; Monetary Contribution Or Donation
- Section 549.0107 - [Effective 4/1/2025] Limitations On Agreement To Accept Program Benefits Instead Of Supplemental Rebates
- Section 549.0108 - [Effective 4/1/2025] Treatment Of Program Benefits For Certain Purposes